CD4 and cancer: The global transcriptomic analysis revealed that in CD4+ T cells co-cultured with MDA-MB-231 cancer cells (T15M), 3564 genes were upregulated and 1250 genes exhibited reduced expression levels when compared to CD4+ T cells stimulated for 12 days (T12) (Figure 2A).